AU2270092A - Methods and compositions for treating pulmonary and cardiac disorders using optically pure (-)pirbuterol - Google Patents

Methods and compositions for treating pulmonary and cardiac disorders using optically pure (-)pirbuterol

Info

Publication number
AU2270092A
AU2270092A AU22700/92A AU2270092A AU2270092A AU 2270092 A AU2270092 A AU 2270092A AU 22700/92 A AU22700/92 A AU 22700/92A AU 2270092 A AU2270092 A AU 2270092A AU 2270092 A AU2270092 A AU 2270092A
Authority
AU
Australia
Prior art keywords
pirbuterol
compositions
methods
optically pure
treating pulmonary
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU22700/92A
Inventor
James W. Young
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sunovion Pharmaceuticals Inc
Original Assignee
Sepracor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sepracor Inc filed Critical Sepracor Inc
Publication of AU2270092A publication Critical patent/AU2270092A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU22700/92A 1991-06-26 1992-06-25 Methods and compositions for treating pulmonary and cardiac disorders using optically pure (-)pirbuterol Abandoned AU2270092A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US72105691A 1991-06-26 1991-06-26
US721056 1991-06-26

Publications (1)

Publication Number Publication Date
AU2270092A true AU2270092A (en) 1993-01-25

Family

ID=24896354

Family Applications (1)

Application Number Title Priority Date Filing Date
AU22700/92A Abandoned AU2270092A (en) 1991-06-26 1992-06-25 Methods and compositions for treating pulmonary and cardiac disorders using optically pure (-)pirbuterol

Country Status (2)

Country Link
AU (1) AU2270092A (en)
WO (1) WO1993000091A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE9218977U1 (en) * 1992-01-17 1996-08-08 Schoeller-Plast S.A., Romont Containers made of plastic, in particular vegetable containers, with foldable side walls

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3700681A (en) * 1971-02-16 1972-10-24 Pfizer 2-hydroxymethyl-3-hydroxy-6-(1-hydroxy-2-aminoethyl)pyridines
US4812455A (en) * 1984-10-11 1989-03-14 Pfizer Inc. Antiinflammatory compositions and methods

Also Published As

Publication number Publication date
WO1993000091A1 (en) 1993-01-07

Similar Documents

Publication Publication Date Title
AU6904498A (en) Methods and compositions for treating gastric disorders using optically pure (-) pantoprazole
EP0748219B8 (en) Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis
AU6691690A (en) Cleaning composition
AU1989792A (en) Multi-purpose dental applicator
EP0647134A4 (en) Methods and compositions for treating depression and other disorders using optically pure (-) sibutramine.
AU4676997A (en) Methods of using (-) cisapride for the treatment of gastro-esophageal reflux disease and other disorders
IT8922168A0 (en) PROCEDURE FOR THE TREATMENT OF FIR WOOD AND HARDWOOD
AU624067B2 (en) Preparation suitable for use in the treatment of enteric disorders
EP0432856A3 (en) Use of rolipram in the treatment of dementia
AU1970592A (en) Method to treat kaposi's sarcoma
EP0700292A4 (en) Methods and compositions for treating gastric disorders using optically pure (+) pantoprazole
EP0711159A4 (en) Methods and compositions for treating asthma, atherosclerosis andinflammatory diseases using optically pure (-)-zileuton
AU3175989A (en) Compositions and methods for cleaning the gums
AU4876390A (en) Water treatment
AU1658992A (en) Methods and compositions for treating pulmonary disorders using optically pure terbutaline
AU2270092A (en) Methods and compositions for treating pulmonary and cardiac disorders using optically pure (-)pirbuterol
AU2135988A (en) Benzopyridazinone and pyridopyridazinone compounds and their use in the treatment of congestive heart failure
AU2305092A (en) Methods and compositions for treating pulmonary and cardiac disorders using optically pure (+) pirbuterol
AU9159891A (en) Compositions and methods for achieving improved physiological response to exercice
AU2297192A (en) Optically pure s(-) nadolol for treatment of cardiovascular disorders
GB9107569D0 (en) Wood treatment
AU3084992A (en) 1,4-dihydropyridines for use in the treatment of dermatosis
GB9100970D0 (en) Acne treatment composition
AU2221497A (en) Methods and compositions for treating hypertension, angina, and other disorders using optically pure S(-) felodipine
AU646941B2 (en) Process for the preparation of 2-pyridylsulfonylureas, and thiadiazoloptridines as intermediates in this process